SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 219 participants.

Also called NCT04511247

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 219 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04511247
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Singapore, Taiwan, Thailand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04511247. Randomized; quadruple masking; primary purpose treatment. Start 2020-08-15 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease
Acronym
FUTURE-BTK
Condition
Peripheral Artery Disease
Condition
Atherosclerosis
Condition
Arterial Disease of Legs
Intervention (Device)
MagicTouch PTA Sirolimus drug coated balloon
Intervention (Device)
POBA balloon
Lead sponsor
Concept Medical Inc. (class: industry)

Record details

Record id
cardio:ct-nct04511247
Content hash
67b913cb6cc9b387241906ebf7fbdb31006d9bf9c4f181ae70c0caf3b764d985